NXGL 3.05 NEXGEL, Inc.
| Range: | 1.46-3.24 | Vol Avg: | 58140 | Last Div: | 0 | Changes: | -0.01 |
| Beta: | 0.75 | Cap: | 0.03B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed Dec 22 2021 | Empoloyees: | 19 | ||
| CUSIP: | 65344E107 | CIK: | 0001468929 | ISIN: | US65344E1073 | Country: | US |
| CEO: | Mr. Adam R. Levy | Website: | https://nexgel.com | ||||
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Stock Details
Positive 0.47
NEXGEL to Participate in Upcoming October Investor Conferences
LANGHORNE, Pa., Oct. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”)...
globenewswire.com·Fri Oct 11 2024
Positive 0.45
NEXGEL Appoints Kip Crecca to its Scientific Advisory Board
LANGHORNE, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”)...
globenewswire.com·Fri Oct 04 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow